digital how-do-we-unlock-potential-digital-health 
pharmaphorum
APRIL 23, 2024
Unlock the power of digital health through AI and clinical advancements. Learn how these technologies are shaping the future of healthcare and how to harness their potential.
pharmaphorum
JANUARY 25, 2023
Digital therapeutics company Woebot Health has announced enrolment of the first patient in a pivotal clinical trial to evaluate the safety and efficacy of WB001, an investigational therapeutic for postpartum depression (PPD), granted Breakthrough Device designation by the US Food and Drug Administration (FDA) in 2021.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
SEPTEMBER 22, 2022
Cut off from tried and tested methods of engaging with stakeholders, digital, and virtual solutions were thrust into the limelight as the industry proactively accelerated the adoption of technology across all levels of healthcare. We chart the unusual metamorphosis of pharma marketing, from patent pages to personalised apps.
pharmaphorum
MAY 18, 2022
In everything we do, our guiding question is: What difference will this make for patients?” The next consideration typically is how do we help ensure those patients who benefit from treatment can access it. We are committed to continuing our efforts to lead in this space.”.
Pharmaceutical Technology
NOVEMBER 4, 2022
billion) per year by the end of the Parliament in additional funding for the National Health Service (NHS), thus raising the agency’s funding by over 29%. These are significant to the business and [it] will be catastrophic if we lost them.” UK’s competitive potential. This would come from “£16.3 says O’Meara.
Drug Discovery World
MARCH 5, 2024
We now commonly refer to epilepsy as ‘epilepsies’, with the recognition that it isn’t a singular disease. SD : At UCB, we currently have several drug discovery projects running, which we are very excited about. LR: Can you share the latest epilepsy research trends? SD : There are multiple types of epilepsy.
pharmaphorum
MAY 20, 2022
Not only do these sites offer a wide array of patient knowledge and medical expertise, but they can also have great benefits for clinical trial recruitment. We recruited a large number of patients to commercial and non-commercial studies. Now, we are hoping that we can maintain the momentum and continue in the same way.”.
Expert insights. Personalized for you.
122 
Let's personalize your content